"It’s crucial that patients and their families know about this new option," said Dr. William Russell, an oncology radiologist ...

The Greek director of the positron emission tomography (PET/CT) scanner at the DFKZ research centre in Heidelberg talks about ...

Moderately hypofractionated and conventionally fractionated radiotherapy demonstrate similar efficacy, but one ...

The radiopharmaceutical lutetium 177 can be used after radium 223 to treat metastatic castration-resistant prostate cancer.

Dan Nardi, MS, CEO of Reimagine Care, claims that on-demand cancer treatment via telehealth is the future of oncology care delivery.